CLINICAL_TRIALS
trial_result
· 2019-05-10
Clinical Trial Update: Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 [Phase 1]
Summary
Phase 1 gene transfer trial for Spinal Muscular Atrophy Type 1 has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Gene Therapies | Conditions: Spinal Muscular Atrophy 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-05-10